“Our study demonstrated in a large real-world population that long-term treatment of up to 5 years with adalimumab in adult patients with psoriasis led to a sustained improvement in the practice of ...
The skin is the largest organ in the human body. Its softness allows for movement and flexibility, yet it is also durable enough to typically resist breaking or tearing. As one of the body's more ...
Mumbai-based Sun Pharma has introduced its global innovative biologic Ilumya (Tildrakizumab) in India for the treatment of ...
Despite challenges such as high costs and access barriers, the demand for effective, tailored therapies continues to rise, transforming the psoriasis treatment landscapeDublin, Nov. 26, 2025 (GLOBE ...
An expert panel calls the requirement for tuberculosis testing before prescribing IL-17 and IL-23 biologics for psoriasis an ...
Innovent Biologics ( ($HK:1801) ) has provided an announcement. Innovent Biologics has announced that its new drug, PECONDLE® (picankibart ...
For the 7.5 million Americans diagnosed with psoriasis, it can be disheartening to hear that there's no cure. But there are several treatments that can help keep this autoimmune disease under control.
Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to ...
Itchy, flaky psoriasis is never fun, but it can also sometimes be downright painful. Working with your derm to find the right treatment option is crucial, but with so many potential options to choose ...
While psoriasis has traditionally been treated "ab initio" with topical medications (corticosteroids, vitamin D (3), and retinoid derivatives), either singly, in combination, or with ultraviolet B ...
Psoriasis is a chronic, immune-mediated skin condition. It causes red, scaly, itchy, often inflamed patches. Because the ...
Can exposure to the sun or other specific types of light help those dealing with chronic psoriasis? We took a look at the science behind phototherapy, also known as light therapy, to see how the ...